» Articles » PMID: 15881180

[Enema Therapy for Ulcerative Colitis Patients]

Overview
Journal Nihon Rinsho
Specialty General Medicine
Date 2005 May 11
PMID 15881180
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The therapeutic options for the treatment of mildly to moderately active distal colitis or distal flare up of total colitis have increased over the last decade. Many reports have documented the effectiveness of various compounds, such as 5-aminosalicylic acid, steroids, cytoprotective agents, lidocaine gel, short chain fatty acid, and cyclosporine when they are applied topically to the inflamed distal colon in patients with ulcerative colitis. These treatments have considerably attracted our attention because of their possible anti-inflammatory effects on ulcerative colitis with lower toxicity. Larger, controlled studies will be necessary to establish the roles of enema therapy in patients with distal colitis.

Citing Articles

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN).

Matthes H, Krummenerl T, Giensch M, Wolff C, Schulze J BMC Complement Altern Med. 2010; 10:13.

PMID: 20398311 PMC: 2861635. DOI: 10.1186/1472-6882-10-13.